Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	16.89M +191.2%
Revenue (ttm)	8.91M +5.9%
Net Income	10.77M
EPS	n/a
Shares Out	94.87M
PE Ratio	1.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	274,164
Open	0.1780
Previous Close	0.1756
Day's Range	0.1758 - 0.1816
52-Week Range	0.0692 - 0.2315
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 8, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 61
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT